US3934036AExpiredUtility

N-benzenesulfonyl-β-alanine hydrazide useful as an immunosuppressive agent

83
Assignee: KYORIN SEIYAKU KKPriority: Jan 23, 1975Filed: Jan 23, 1975Granted: Jan 20, 1976
Est. expiryJan 23, 1995(expired)· nominal 20-yr term from priority
Inventors:Tsutomu Irikura
A61K 31/18
83
PatentIndex Score
37
Cited by
1
References
5
Claims

Abstract

The present invention relates to a valuable medicament for oral administration containing N-benzenesulfonyl- beta -alanine hydrazide as an effective ingredient. The drug of this invention is useful, as an immunosuppressive agent, for suppression of so-called autoimmune diseases such as nephrotic syndromes, rheumatoid arthritis and systemic lupus erythematosus etc.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A pharmaceutical composition in oral dosage unit form comprising a pharmaceutical carrier and from about 20 to 400 mg per unit of N-benzenesulfonyl-β-alanine hydrazide. 
     
     
       2. A pharmaceutical composition in accordance with claim 1, in which a solid pharmaceutical carrier is employed. 
     
     
       3. A pharmaceutical composition in accordance with claim 1, in which a liquid pharmaceutical carrier is employed. 
     
     
       4. A method of treating autoimmune disease in the human body comprising administering an effective amount of the composition of claim 1. 
     
     
       5. A method of treating autoimmune disease in the human body comprising administering a therapeutic composition in oral dosage unit form comprising a pharmaceutical carrier and an effective amount of N-benzenesulfonyl-β-alanine hydrazide.

Join the waitlist — get patent alerts

Track US3934036A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.